Dr Daniel Henderson
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr-Daniel-Henderson.jpg

Dr Daniel Henderson

Dr Daniel Henderson
Daniel
Henderson
MB BS, MRCP, FRCR Postgraduate Diploma in Oncology Institute of Cancer Research, Clinical oncologist

Languages spoken

English

Expert in

Drug and radiation treatments, cyberknife and heart sparing techniques

Overview

Centres

Birmingham
Birmingham

Little Aston Hall Drive, Sutton Coldfield, B74 3BF

52.60208, -1.87412
/uk/our-centres/birmingham
+44 (0) 121 353 3055
mediahawkNumber3664 mhMobile

Treatments

Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Radiotherapy

Specialises in

Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast cancer

Dr Daniel Henderson is a Clinical Oncologist specialising in the treatment of breast and prostate cancer. Dr Henderson trained at the Royal Marsden Hospital including research in advanced radiotherapy. He is an expert in drug and radiation treatments for early and advanced breast and prostate cancer, including Cyberknife and heart sparing techniques.

He has published several research papers and spoken at national and international conferences. He was appointed as a Consultant in Clinical Oncology at Queen Elizabeth Hospital in Edgbaston and Good Hope Hospital in Sutton Coldfield in November 2017, caring for patients with Breast and prostate cancer. His focus is on developing a personalised treatment plan for each patient to achieve the best possible outcomes.

Careerpositions

Career positions

Current position(s)

  • Clinical oncologist at Genesis, Birmingham 

Past position(s)

  • Consultant in Clinical Oncology at Queen Elizabeth Hospital in Edgbaston and Good Hope Hospital in Sutton Coldfield in November 2017

Expertise and interests

Interests

  • Breast cancer
  • Cyberknife

Professional memberships

  • Fellow of the Royal College of Radiologists (FRCR)
  • Member of the Royal College of Physicians (MRCP)
  • He is a member of the Expert Advisory Group for both Breast Cancer in the West Midlands and sits on the Scientific Advisory Committee for clinical trials at the Queen Elizabeth Hospital.